Copyright ©The Author(s) 2021.
World J Gastroenterol. Jul 14, 2021; 27(26): 4182-4193
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4182
Table 1 Recommendations for antiviral treatment in pregnant women with chronic hepatitis B virus infection
HBV-DNA level
When to start treatment
When to stop treatment
American Association for the Study of Liver Diseases[25]Tenofovir disoproxil fumarate> 2 × 105 IU/mL 28-32 wkAt birth to 3 mo
European Association for the Study of the Liver[24]Tenofovir disoproxil fumarate> 2 × 105 IU/mL24-28 wkUp to 12 wk after delivery
Asian Pacific Association for the Study of the Liver[70]Tenofovir disoproxil fumarate, telbivudine> 106-7 IU/mL28-32 wkAt delivery
Chinese Medical Association[71]Tenofovir disoproxil fumarate, telbivudine, lamivudine> 2 × 106 IU/mL24-28 wkAt delivery
National Institute for Health and Care Excellence[72]Tenofovir disoproxil fumarate> 107 IU/mL3rd trimester4-12 wk after birth